Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | – |
| % Growth | 0% | -6.3% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | 51.8% | 51.8% | 54.3% | – |
| R&D Expenses | $0 | $0 | $0 | – |
| G&A Expenses | $0 | $0 | $0 | – |
| SG&A Expenses | $0 | $0 | $0 | – |
| Sales & Mktg Exp. | $0 | $0 | $0 | – |
| Other Operating Expenses | -$0 | -$0 | -$0 | – |
| Operating Expenses | $0 | $0 | $0 | – |
| Operating Income | $0 | $0 | $0 | – |
| % Margin | 9.7% | 9.7% | 6.1% | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | – |
| Pre-Tax Income | $0 | $0 | $0 | – |
| Tax Expense | $0 | $0 | $0 | – |
| Net Income | $0 | $0 | $0 | – |
| % Margin | 9.7% | 9.7% | 4.1% | – |
| EPS | 0.057 | 0.057 | 0.026 | – |
| % Growth | 0% | 119.2% | – | – |
| EPS Diluted | 0.057 | 0.057 | 0.026 | – |
| Weighted Avg Shares Out | 1 | 1 | 1 | – |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $0 | $0 | $0 | – |
| EBITDA | $0 | $0 | $0 | – |
| % Margin | 19.9% | 19.9% | 11.2% | – |